The donor graft contains both mature immune cells and primitive HSCs. T cells facilitate engraftment, protect against infection, and mediate an antileukemic effect. However, they may also initiate GVHD, a potentially fatal transplant complication. HSCs restore hematopoiesis and native immunity, the latter process requiring education of immune cells in the host thymus.